JPMorgan Chase & Co’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.82M | Buy |
940,483
+396,858
| +73% | +$3.72M | ﹤0.01% | 2309 |
|
2025
Q1 | $3.87M | Sell |
543,625
-14,893
| -3% | -$106K | ﹤0.01% | 2841 |
|
2024
Q4 | $6.51M | Sell |
558,518
-90,536
| -14% | -$1.06M | ﹤0.01% | 2564 |
|
2024
Q3 | $13.3M | Sell |
649,054
-20,051
| -3% | -$412K | ﹤0.01% | 1972 |
|
2024
Q2 | $15M | Buy |
669,105
+125,998
| +23% | +$2.82M | ﹤0.01% | 1836 |
|
2024
Q1 | $14.9M | Sell |
543,107
-93,010
| -15% | -$2.56M | ﹤0.01% | 1881 |
|
2023
Q4 | $19.4M | Buy |
636,117
+21,101
| +3% | +$643K | ﹤0.01% | 1660 |
|
2023
Q3 | $19.4M | Sell |
615,016
-38,334
| -6% | -$1.21M | ﹤0.01% | 1527 |
|
2023
Q2 | $26.6M | Sell |
653,350
-17,782
| -3% | -$725K | ﹤0.01% | 1371 |
|
2023
Q1 | $25M | Buy |
671,132
+8,515
| +1% | +$317K | ﹤0.01% | 1333 |
|
2022
Q4 | $23.1M | Buy |
662,617
+21,770
| +3% | +$760K | ﹤0.01% | 1336 |
|
2022
Q3 | $35.9M | Sell |
640,847
-1,617
| -0.3% | -$90.5K | 0.01% | 1089 |
|
2022
Q2 | $33.3M | Buy |
642,464
+14,495
| +2% | +$750K | ﹤0.01% | 1146 |
|
2022
Q1 | $45.6M | Sell |
627,969
-40,398
| -6% | -$2.94M | 0.01% | 1097 |
|
2021
Q4 | $79M | Buy |
668,367
+174,640
| +35% | +$20.6M | 0.01% | 901 |
|
2021
Q3 | $66.2M | Sell |
493,727
-402,850
| -45% | -$54M | 0.01% | 967 |
|
2021
Q2 | $145M | Sell |
896,577
-5,357
| -0.6% | -$867K | 0.02% | 683 |
|
2021
Q1 | $72.4M | Buy |
901,934
+284,110
| +46% | +$22.8M | 0.01% | 930 |
|
2020
Q4 | $33.6M | Buy |
617,824
+189,628
| +44% | +$10.3M | ﹤0.01% | 1152 |
|
2020
Q3 | $9.25M | Buy |
428,196
+117,915
| +38% | +$2.55M | ﹤0.01% | 1829 |
|
2020
Q2 | $6.52M | Buy |
310,281
+86,659
| +39% | +$1.82M | ﹤0.01% | 1985 |
|
2020
Q1 | $2.74M | Buy |
223,622
+97,807
| +78% | +$1.2M | ﹤0.01% | 2399 |
|
2019
Q4 | $1.85M | Buy |
125,815
+113,140
| +893% | +$1.66M | ﹤0.01% | 2745 |
|
2019
Q3 | $169K | Buy |
12,675
+2,675
| +27% | +$35.7K | ﹤0.01% | 3810 |
|
2019
Q2 | $152K | Buy |
10,000
+1,894
| +23% | +$28.8K | ﹤0.01% | 3866 |
|
2019
Q1 | $138K | Sell |
8,106
-381
| -4% | -$6.49K | ﹤0.01% | 3899 |
|
2018
Q4 | $116K | Buy |
8,487
+792
| +10% | +$10.8K | ﹤0.01% | 3987 |
|
2018
Q3 | $220K | Buy |
7,695
+947
| +14% | +$27.1K | ﹤0.01% | 3839 |
|
2018
Q2 | $185K | Sell |
6,748
-21,136
| -76% | -$579K | ﹤0.01% | 3850 |
|
2018
Q1 | $588K | Buy |
27,884
+24,289
| +676% | +$512K | ﹤0.01% | 3313 |
|
2017
Q4 | $69K | Buy |
+3,595
| New | +$69K | ﹤0.01% | 4027 |
|
2017
Q2 | – | Sell |
-3,302
| Closed | -$47K | – | 4441 |
|
2017
Q1 | $47K | Buy |
+3,302
| New | +$47K | ﹤0.01% | 3942 |
|
2016
Q3 | – | Sell |
-60,925
| Closed | -$1.3M | – | 4190 |
|
2016
Q2 | $1.3M | Buy |
+60,925
| New | +$1.3M | ﹤0.01% | 2648 |
|